Form 4: Accelerate Diagnostics CEO Jack Phillips Reports Stock Transactions
SEC Form 4 Filing
CEO Jack Phillips of Accelerate Diagnostics reports the vesting of restricted stock units and subsequent sale of shares to cover tax obligations.
Summary
- On April 4, 2024, Jack Phillips, CEO of Accelerate Diagnostics, reported transactions involving the company's stock.
- Phillips vested 35,523 restricted stock units (RSUs) that were granted on April 4, 2022, as part of a total grant of 88,806 RSUs.
- 40% of the RSUs vested on April 4, 2024, and the remaining 60% will vest on April 4, 2025.
- Each RSU represents the right to receive one share of Accelerate Diagnostics common stock upon vesting.
- Phillips also sold 15,887 shares at a price of $0.88 per share.
- The sale was executed to cover tax withholding obligations related to the vesting and settlement of the RSUs and was not a discretionary transaction.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing stock transactions. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates the CEO's stock transactions related to vested equity compensation.
Stakeholder Impact
- The sale of shares by the CEO could have a minor impact on the stock price, but it is primarily driven by tax obligations and not a discretionary sale.
Key Dates
| Date | Description |
|---|---|
| 04/04/2022 | Reporting person was granted a total of 88,806 restricted stock units ('RSUs') |
| 04/04/2024 | 40% of the RSUs vest |
| 04/04/2024 | Reporting person vested 35,523 restricted stock units and sold 15,887 shares to cover tax obligations. |
| 04/04/2025 | Remaining 60% of the RSUs vest |
| 04/05/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.